MaxCyte

MaxCyte adds Arthur Mandell, Judith Hedstrom, and Carl June, MD

Published in Health Business Week, October 13th, 2006

MaxCyte, Inc., a clinical-stage therapeutic company and pioneer in clinical-scale cell-loading systems for cellular therapy announced the addition of three individuals to its leadership team.

Arthur Mandell was elected to MaxCyte's board of directors, Judith Hedstrom joined the executive team in the new role of senior vice president, corporate and business development, and Carl June, MD, became a member of MaxCyte's roster of scientific and medical advisors.

Mandell joined Prestwick Pharmaceuticals in November 2005 as president and COO and currently serves as executive strategic advisor. Mandell has also served as a director of the company since...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health Business Week

Source: Health Business Week (2006-10-13)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry